Go Pro

New York Times (NYT) Financials

New York Times logo
$70.08 +0.14 (+0.19%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$70.22 +0.14 (+0.20%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for New York Times

Annual Income Statements for New York Times

This table shows New York Times' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/27/2015 12/25/2016 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
63 29 4.30 126 140 100 220 174 232 294 344
Consolidated Net Income / (Loss)
63 24 6.84 127 140 101 220 174 233 294 344
Net Income / (Loss) Continuing Operations
63 26 7.27 127 140 101 220 174 233 294 344
Total Pre-Tax Income
97 31 111 176 164 115 291 236 303 383 451
Total Operating Income
137 113 177 190 176 176 268 202 276 351 432
Total Gross Profit
961 926 1,413 796 824 824 1,035 1,099 1,177 1,276 1,435
Total Revenue
1,579 1,555 1,666 1,744 1,812 1,784 2,075 2,308 2,426 2,586 2,825
Operating Revenue
1,490 1,555 1,666 1,744 1,812 1,784 2,075 2,308 2,426 2,586 2,825
Total Cost of Revenue
618 629 253 948 988 959 1,040 1,209 1,249 1,310 1,390
Operating Cost of Revenue
618 629 253 948 988 959 1,040 1,209 1,249 1,310 1,390
Total Operating Expenses
825 813 1,236 606 648 648 767 897 901 925 1,004
Selling, General & Admin Expense
714 728 815 197 207 224 250 289 311 308 328
Marketing Expense
- - - 271 273 229 295 268 260 278 307
Research & Development Expense
- - - 84 106 133 161 204 229 248 264
Depreciation Expense
62 62 62 59 61 62 58 83 86 83 85
Other Operating Expenses / (Income)
49 6.73 359 -4.85 -2.05 0.00 0.00 15 -0.61 -2.98 2.97
Impairment Charge
- - - - - 0.00 0.00 4.07 15 0.00 2.86
Other Special Charges / (Income)
0.00 - - - 0.00 0.00 3.83 0.00 0.00 11 13
Total Other Income / (Expense), net
-40 -82 -65 -14 -11 -61 22 34 26 32 20
Interest & Investment Income
-0.78 -36 19 11 0.00 5.00 0.00 41 24 36 38
Other Income / (Expense), net
- -11 -64 -8.27 -7.30 -89 -10 -6.66 2.74 -4.16 -19
Income Tax Expense
34 4.42 104 49 24 15 71 62 70 90 107
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.40 -5.24 2.54 1.78 0.00 0.73 0.00 0.00 0.37 0.00 0.00
Basic Earnings per Share
$0.38 $0.18 $0.03 $0.76 $0.84 $0.60 $1.31 $1.04 $1.41 $1.79 $2.11
Weighted Average Basic Shares Outstanding
164.39M 161.13M 161.93M 164.85M 166.04M 166.97M 167.93M 166.87M 164.72M 164.43M 163.16M
Diluted Earnings per Share
$0.38 $0.18 $0.03 $0.75 $0.83 $0.60 $1.31 $1.04 $1.40 $1.77 $2.09
Weighted Average Diluted Shares Outstanding
166.42M 162.82M 164.26M 166.94M 167.55M 168.04M 168.53M 167.14M 165.66M 165.80M 164.94M
Weighted Average Basic & Diluted Shares Outstanding
166.40M 161.50M 143.20M 165.40M 166.40M 167.44M 167.53M 164.47M 164.10M 163.30M 161.24M
Cash Dividends to Common per Share
$0.16 $0.16 $0.16 $0.16 $0.20 $0.24 $0.28 $0.36 $0.44 $0.52 $0.72

Quarterly Income Statements for New York Times

This table shows New York Times' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
110 40 66 64 124 50 83 82 130 88 93
Consolidated Net Income / (Loss)
110 40 66 64 124 50 83 82 130 88 93
Net Income / (Loss) Continuing Operations
110 40 66 64 124 50 83 82 130 88 93
Total Pre-Tax Income
140 56 87 85 156 64 112 108 168 98 125
Total Operating Income
129 48 79 77 147 59 107 105 162 91 118
Total Gross Profit
355 277 302 308 389 301 347 352 435 349 395
Total Revenue
676 594 625 640 727 636 686 701 802 712 762
Operating Revenue
676 594 625 640 727 636 686 701 802 712 762
Total Cost of Revenue
321 317 323 332 338 335 339 349 367 363 368
Operating Cost of Revenue
321 317 323 332 338 335 339 349 367 363 368
Total Operating Expenses
226 229 223 232 242 243 241 247 274 259 277
Selling, General & Admin Expense
76 79 77 76 76 80 83 77 89 86 86
Marketing Expense
68 65 61 69 83 66 69 80 92 77 86
Research & Development Expense
58 63 62 61 62 67 64 67 67 70 70
Depreciation Expense
22 21 21 21 21 21 21 21 21 21 21
Other Operating Expenses / (Income)
- 0.00 0.00 0.00 - 4.45 0.00 0.00 -1.49 0.00 9.22
Other Special Charges / (Income)
- 0.99 1.98 4.62 3.21 4.40 3.49 2.41 3.02 4.21 4.63
Total Other Income / (Expense), net
11 7.34 7.67 8.32 9.00 5.33 5.11 3.21 6.04 7.70 7.20
Interest & Investment Income
- 8.39 8.70 9.37 - 9.97 9.75 7.85 11 11 11
Other Income / (Expense), net
0.68 -1.05 -1.02 -1.05 -1.03 -4.64 -4.64 -4.64 -4.64 -3.58 -3.64
Income Tax Expense
30 15 22 21 32 14 29 26 38 10 32
Basic Earnings per Share
$0.66 $0.25 $0.40 $0.39 $0.75 $0.30 $0.51 $0.50 $0.80 $0.54 $0.58
Weighted Average Basic Shares Outstanding
164.72M 164.63M 164.54M 164.42M 164.43M 163.78M 163.33M 163.02M 163.16M 162.04M 162.04M
Diluted Earnings per Share
$0.67 $0.24 $0.40 $0.39 $0.74 $0.30 $0.50 $0.50 $0.79 $0.54 $0.57
Weighted Average Diluted Shares Outstanding
165.66M 165.63M 165.51M 165.85M 165.80M 164.91M 164.35M 164.40M 164.94M 163.70M 163.04M
Weighted Average Basic & Diluted Shares Outstanding
164.10M 164.31M 164.23M 163.95M 163.30M 163.05M 162.82M 162.35M 161.24M 161.86M 161.28M
Cash Dividends to Common per Share
$0.11 $0.13 $0.13 $0.13 $0.13 $0.18 $0.18 $0.18 $0.18 $0.23 $0.23

Annual Cash Flow Statements for New York Times

This table details how cash moves in and out of New York Times' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/27/2015 12/25/2016 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-70 -8.68 75 60 -12 54 33 -97 68 -88 57
Net Cash From Operating Activities
179 104 87 157 190 298 269 151 361 411 584
Net Cash From Continuing Operating Activities
179 104 87 157 190 298 269 151 361 411 584
Net Income / (Loss) Continuing Operations
63 24 6.84 127 140 101 220 174 233 294 344
Consolidated Net Income / (Loss)
63 24 6.84 127 140 101 220 174 233 294 344
Depreciation Expense
62 62 62 59 61 62 58 83 86 83 85
Amortization Expense
- - - 0.00 7.38 8.57 9.49 9.92 9.23 9.09 10
Non-Cash Adjustments To Reconcile Net Income
58 48 -78 -35 -15 79 -20 0.76 36 38 90
Changes in Operating Assets and Liabilities, net
-3.84 -29 96 5.52 -2.80 47 2.35 -117 -3.24 -13 56
Net Cash From Investing Activities
-31 124 14 -101 93 -199 -181 -74 -160 -306 -221
Net Cash From Continuing Investing Activities
-31 124 14 -101 93 -199 -181 -74 -160 -306 -221
Purchase of Property, Plant & Equipment
-27 -30 -85 -77 -45 -34 -35 -37 -23 -29 -34
Purchase of Investments
-824 -569 -467 -470 -572 -632 -763 -6.65 -286 -480 -653
Sale and/or Maturity of Investments
818 725 564 446 708 498 614 483 145 191 453
Other Investing Activities, net
1.93 38 1.32 0.43 3.27 2.85 3.72 2.48 4.75 13 13
Net Cash From Financing Activities
-218 -237 -26 3.82 -295 -45 -55 -174 -133 -193 -306
Net Cash From Continuing Financing Activities
-218 -237 -26 3.82 -295 -45 -55 -174 -133 -193 -306
Repurchase of Common Equity
-69 -16 - - - 0.00 0.00 -105 -45 -85 -165
Payment of Dividends
-27 -26 -26 -26 -32 -38 -45 -57 -70 -83 -110
Other Financing Activities, net
-1.45 -6.44 0.54 31 -11 -6.54 -9.61 -12 -18 -25 -30
Cash Interest Paid
41 0.04 28 28 28 0.51 0.55 1.58 0.71 0.72 0.11
Cash Income Taxes Paid
21 0.05 22 -1.07 30 24 66 110 72 113 72

Quarterly Cash Flow Statements for New York Times

This table details how cash moves in and out of New York Times' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
53 -82 17 -18 -5.01 -17 15 52 6.54 -70 47
Net Cash From Operating Activities
137 53 80 126 152 99 114 208 164 92 194
Net Cash From Continuing Operating Activities
137 53 80 126 152 99 114 211 160 92 194
Net Income / (Loss) Continuing Operations
110 40 66 64 124 50 83 82 130 88 93
Consolidated Net Income / (Loss)
110 40 66 64 124 50 83 82 130 88 93
Depreciation Expense
22 21 21 21 21 21 21 21 21 21 21
Amortization Expense
2.05 2.22 2.24 2.31 2.32 2.33 2.34 - - 2.76 2.65
Non-Cash Adjustments To Reconcile Net Income
22 16 13 8.96 20 19 12 23 29 24 21
Changes in Operating Assets and Liabilities, net
-19 -26 -21 29 -16 6.50 -4.56 90 -29 -43 56
Net Cash From Investing Activities
-62 -66 -30 -101 -109 -8.34 -44 -97 -72 -23 -74
Net Cash From Continuing Investing Activities
-62 -66 -30 -101 -109 -8.34 -44 -97 -72 -23 -74
Purchase of Property, Plant & Equipment
-6.13 -6.42 -7.63 -7.06 -8.06 -9.24 -10 -7.88 -6.53 -11 -10
Purchase of Investments
-100 -113 -72 -152 -143 -168 -132 -173 -179 -129 -172
Sale and/or Maturity of Investments
44 52 49 58 31 162 98 78 114 117 108
Other Investing Activities, net
- 0.55 0.81 -0.06 11 7.23 0.32 5.48 -0.21 0.56 -0.11
Net Cash From Financing Activities
-21 -69 -34 -42 -48 -107 -54 -59 -85 -139 -74
Net Cash From Continuing Financing Activities
-21 -69 -34 -42 -48 -107 -54 -59 -85 -139 -74
Repurchase of Common Equity
-0.96 -32 -9.55 -18 -25 -59 -24 -27 -55 -56 -35
Payment of Dividends
-18 -19 -21 -21 -21 -22 -30 -29 -29 -30 -37
Other Financing Activities, net
-1.47 -18 -2.70 -2.49 -2.02 -26 -1.28 -2.25 -0.66 -52 -1.07

Annual Balance Sheets for New York Times

This table presents New York Times' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/27/2015 12/25/2016 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
2,418 2,185 2,100 2,197 2,089 2,308 2,564 2,534 2,715 2,841 2,997
Total Current Assets
863 796 750 894 717 836 953 656 782 936 1,028
Cash & Equivalents
106 101 183 242 230 286 320 221 289 199 255
Short-Term Investments
508 450 309 371 202 309 341 126 162 366 387
Accounts Receivable
207 197 185 222 213 184 233 218 242 250 291
Prepaid Expenses
19 16 23 25 29 29 33 55 60 50 60
Other Current Assets
23 33 50 33 42 27 26 36 28 71 35
Plant, Property, & Equipment, net
632 597 641 639 627 595 575 554 514 489 462
Total Noncurrent Assets
923 792 709 664 745 877 2,964 1,324 1,419 1,416 1,507
Long-Term Investments
314 203 241 214 252 287 413 139 258 346 526
Goodwill
109 135 144 140 139 172 166 414 416 412 409
Intangible Assets
- - - - - - 14 317 285 258 229
Noncurrent Deferred & Refundable Income Taxes
309 301 153 128 115 100 96 96 115 111 73
Other Noncurrent Operating Assets
191 154 171 182 240 319 2,187 288 262 218 270
Total Liabilities & Shareholders' Equity
2,418 2,185 2,100 2,197 2,089 2,308 2,564 2,534 2,715 2,841 2,997
Total Liabilities
1,589 1,341 1,202 1,154 915 980 1,023 934 951 914 956
Total Current Liabilities
564 399 416 673 438 487 559 571 612 614 667
Accounts Payable
96 104 125 112 117 123 127 115 117 124 136
Accrued Expenses
121 131 111 120 124 137 146 136 148 125 137
Current Employee Benefit Liabilities
98 96 105 105 109 121 166 165 174 178 186
Other Current Liabilities
- - 75 84 88 105 119 156 173 187 208
Total Noncurrent Liabilities
1,026 942 787 481 478 493 464 363 340 301 289
Noncurrent Employee Benefit Liabilities
691 617 454 403 351 365 331 252 239 215 211
Other Noncurrent Operating Liabilities
92 79 82 78 126 128 133 111 101 86 78
Total Equity & Noncontrolling Interests
828 844 897 1,043 1,174 1,328 1,541 1,600 1,763 1,927 2,041
Total Preferred & Common Equity
827 848 897 1,041 1,172 1,326 1,539 1,598 1,763 1,927 2,041
Total Common Equity
827 848 897 1,041 1,172 1,326 1,539 1,598 1,763 1,927 2,041
Common Stock
163 167 181 224 226 234 248 273 319 374 430
Retained Earnings
1,329 1,332 1,310 1,506 1,613 1,673 1,845 1,959 2,118 2,325 2,551
Treasury Stock
-156 -171 -171 -171 -171 -171 - -276 -321 -406 -573
Accumulated Other Comprehensive Income / (Loss)
-509 -480 -423 -518 -495 -410 -383 -358 -353 -366 -366

Quarterly Balance Sheets for New York Times

This table presents New York Times' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
2,472 2,479 2,547 2,623 2,673 2,762 2,735 2,805 2,887 2,859 2,985
Total Current Assets
634 675 658 681 716 795 802 855 938 927 1,023
Cash & Equivalents
235 246 236 207 223 205 183 198 249 187 233
Short-Term Investments
139 171 163 172 188 288 339 342 368 408 428
Accounts Receivable
166 159 164 178 181 189 193 211 204 235 236
Prepaid Expenses
58 61 57 59 50 45 50 58 53 59 68
Other Current Assets
35 38 39 65 73 68 37 46 64 39 58
Plant, Property, & Equipment, net
546 531 524 508 503 495 483 478 471 460 455
Total Noncurrent Assets
1,292 1,273 1,365 1,434 1,454 1,472 1,451 1,472 1,478 1,472 1,506
Long-Term Investments
100 94 189 307 313 327 380 411 479 513 555
Goodwill
415 415 413 415 414 417 415 409 409 408 407
Intangible Assets
310 303 293 278 272 265 251 243 236 222 215
Noncurrent Deferred & Refundable Income Taxes
106 116 116 121 128 131 123 128 73 62 50
Other Noncurrent Operating Assets
361 346 353 313 328 332 281 280 280 268 278
Total Liabilities & Shareholders' Equity
2,472 2,479 2,547 2,623 2,673 2,762 2,735 2,805 2,887 2,859 2,985
Total Liabilities
895 872 891 875 868 910 850 869 907 858 937
Total Current Liabilities
540 532 554 545 543 590 555 578 615 578 648
Accounts Payable
122 111 120 121 121 137 122 120 131 138 155
Accrued Expenses
155 125 140 157 123 129 144 134 124 123 133
Current Employee Benefit Liabilities
100 139 138 89 124 146 96 133 162 101 149
Other Current Liabilities
164 157 157 178 175 177 194 190 198 216 211
Total Noncurrent Liabilities
355 340 337 330 325 320 295 291 291 280 289
Noncurrent Employee Benefit Liabilities
249 246 240 236 233 230 215 212 209 207 211
Other Noncurrent Operating Liabilities
106 93 97 94 92 90 80 79 83 73 78
Total Equity & Noncontrolling Interests
1,577 1,607 1,655 1,748 1,805 1,852 1,885 1,936 1,980 2,001 2,048
Total Preferred & Common Equity
1,575 1,605 1,653 1,748 1,805 1,852 1,885 1,936 1,980 2,001 2,048
Total Common Equity
1,575 1,605 1,653 1,748 1,805 1,852 1,885 1,936 1,980 2,001 2,048
Common Stock
273 286 298 317 338 352 365 387 404 396 421
Retained Earnings
1,963 1,991 2,026 2,137 2,180 2,223 2,345 2,398 2,450 2,601 2,657
Treasury Stock
-307 - -320 -354 - -382 -466 -489 -517 -629 -665
Accumulated Other Comprehensive Income / (Loss)
-354 -352 -351 -352 -350 -342 -360 -360 -357 -366 -365

Annual Metrics And Ratios for New York Times

This table displays calculated financial ratios and metrics derived from New York Times' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/27/2015 12/25/2016 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.59% -1.51% 7.09% 4.72% 3.90% -1.58% 16.33% 11.25% 5.10% 6.59% 9.24%
EBITDA Growth
15.62% -17.59% 6.68% 38.26% -1.90% -33.23% 105.66% -11.30% 30.04% 17.26% 15.76%
EBIT Growth
48.55% -25.61% 10.59% 61.88% -7.48% -48.24% 195.69% -24.17% 42.86% 24.35% 19.04%
NOPAT Growth
-13.75% 8.62% -88.02% 1,092.85% 8.56% 3.04% 31.82% -26.67% 42.79% 26.61% 22.27%
Net Income Growth
94.53% -62.08% -71.31% 1,764.27% 9.81% -27.96% 118.15% -20.94% 33.84% 26.24% 17.07%
EPS Growth
90.00% -52.63% -83.33% 2,400.00% 10.67% -27.71% 118.33% -20.61% 34.62% 26.43% 18.08%
Operating Cash Flow Growth
122.48% -41.99% -16.52% 81.19% 20.86% 56.89% -9.68% -44.00% 139.32% 13.84% 42.38%
Free Cash Flow Firm Growth
-32.27% -31.17% -171.79% 226.69% 57.02% 52.87% -982.08% 181.90% -80.95% 13.06% 52.99%
Invested Capital Growth
-11.44% 1.73% 22.65% 13.32% 4.27% -8.95% 436.59% -53.48% -5.36% -3.67% -13.97%
Revenue Q/Q Growth
0.00% -0.32% 2.54% 1.18% 0.39% 31.56% -14.15% 3.28% 0.36% 1.99% 2.75%
EBITDA Q/Q Growth
11.22% -16.37% -19.12% 26.24% 4.88% -32.85% 39.45% 2.63% 11.46% 3.61% 4.38%
EBIT Q/Q Growth
22.67% -24.01% -26.43% 37.85% 2.15% -47.26% 56.82% -0.09% 15.99% 4.80% 2.82%
NOPAT Q/Q Growth
5.46% 8.30% -88.55% 436.76% 13.74% 3.64% 1.35% -0.56% 17.33% 5.80% 2.66%
Net Income Q/Q Growth
39.66% -37.09% -93.32% 907.99% 8.73% -36.30% 36.78% 0.52% 20.41% 4.81% 1.81%
EPS Q/Q Growth
35.71% -30.77% -95.00% 837.50% 9.21% -36.17% 39.36% -0.95% 21.74% 4.12% 2.45%
Operating Cash Flow Q/Q Growth
17.59% -33.70% -47.80% 184.67% 16.97% 8.35% -10.54% 4.23% 24.45% 3.84% 2.18%
Free Cash Flow Firm Q/Q Growth
-47.43% -47.64% -244.63% 176.43% 4.79% 25.59% -857.39% 387.48% 45.26% 6.08% 0.46%
Invested Capital Q/Q Growth
-5.85% 25.72% 27.71% 2.57% 5.13% -2.40% 460.61% 3.72% -1.26% -1.58% -1.13%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
60.88% 59.54% 84.83% 45.65% 45.47% 46.22% 49.90% 47.63% 48.52% 49.36% 50.81%
EBITDA Margin
12.55% 10.50% 10.46% 13.81% 13.04% 8.85% 15.64% 12.47% 15.43% 16.98% 17.99%
Operating Margin
8.65% 7.24% 10.60% 10.90% 9.69% 9.88% 12.92% 8.75% 11.39% 13.58% 15.28%
EBIT Margin
8.65% 6.53% 6.75% 10.43% 9.29% 4.88% 12.41% 8.46% 11.50% 13.42% 14.62%
Profit (Net Income) Margin
3.98% 1.53% 0.41% 7.31% 7.72% 5.65% 10.60% 7.53% 9.59% 11.36% 12.18%
Tax Burden Percent
64.95% 78.07% 6.15% 72.38% 85.11% 87.36% 75.72% 73.69% 76.92% 76.63% 76.23%
Interest Burden Percent
70.84% 30.04% 98.98% 96.81% 97.73% 132.53% 112.79% 120.83% 108.45% 110.52% 109.26%
Effective Tax Rate
35.05% 14.48% 93.47% 27.62% 14.89% 12.64% 24.28% 26.31% 23.08% 23.37% 23.77%
Return on Invested Capital (ROIC)
25.08% 28.75% 3.07% 31.12% 31.14% 32.90% 14.29% 8.49% 19.61% 26.00% 34.83%
ROIC Less NNEP Spread (ROIC-NNEP)
31.17% 43.22% 4.02% 33.05% 32.64% 39.68% -103.53% 22.16% 16.22% 22.95% 33.39%
Return on Net Nonoperating Assets (RNNOA)
-17.00% -25.90% -2.28% -17.98% -18.51% -24.84% 1.04% 2.59% -5.77% -10.08% -17.50%
Return on Equity (ROE)
8.07% 2.85% 0.79% 13.14% 12.63% 8.06% 15.34% 11.07% 13.84% 15.92% 17.34%
Cash Return on Invested Capital (CROIC)
37.21% 27.03% -17.28% 18.63% 26.96% 42.26% -122.87% 81.48% 25.11% 29.74% 49.85%
Operating Return on Assets (OROA)
5.48% 4.41% 5.24% 8.47% 7.85% 3.96% 10.57% 7.66% 10.63% 12.49% 14.15%
Return on Assets (ROA)
2.52% 1.04% 0.32% 5.93% 6.53% 4.59% 9.03% 6.82% 8.87% 10.58% 11.78%
Return on Common Equity (ROCE)
8.05% 2.85% 0.79% 13.13% 12.61% 8.05% 15.31% 11.06% 13.83% 15.92% 17.34%
Return on Equity Simple (ROE_SIMPLE)
7.60% 2.81% 0.76% 12.25% 11.94% 7.61% 14.30% 10.88% 13.20% 15.25% 0.00%
Net Operating Profit after Tax (NOPAT)
89 96 12 138 149 154 203 149 213 269 329
NOPAT Margin
5.62% 6.20% 0.69% 7.89% 8.25% 8.63% 9.78% 6.45% 8.76% 10.40% 11.65%
Net Nonoperating Expense Percent (NNEP)
-6.09% -14.47% -0.95% -1.93% -1.51% -6.79% 117.83% -13.67% 3.39% 3.06% 1.44%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.30% 12.05% 13.96% 16.12%
Cost of Revenue to Revenue
39.12% 40.46% 15.17% 54.35% 54.53% 53.78% 50.10% 52.37% 51.48% 50.64% 49.19%
SG&A Expenses to Revenue
45.20% 46.83% 48.94% 11.27% 11.41% 12.53% 12.05% 12.53% 12.82% 11.91% 11.61%
R&D to Revenue
0.00% 0.00% 0.00% 4.82% 5.87% 7.48% 7.75% 8.85% 9.43% 9.60% 9.36%
Operating Expenses to Revenue
52.23% 52.29% 74.23% 34.75% 35.78% 36.33% 36.98% 38.88% 37.13% 35.78% 35.53%
Earnings before Interest and Taxes (EBIT)
137 102 112 182 168 87 258 195 279 347 413
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
198 163 174 241 236 158 325 288 374 439 508
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.49 2.42 3.17 3.39 4.36 6.26 5.03 3.28 4.51 4.42 5.51
Price to Tangible Book Value (P/TBV)
2.87 2.88 3.77 3.92 4.95 7.19 5.69 6.05 7.49 6.77 8.01
Price to Revenue (P/Rev)
1.30 1.32 1.71 2.02 2.82 4.65 3.73 2.27 3.28 3.29 3.98
Price to Earnings (P/E)
32.56 70.72 662.05 28.06 36.53 82.92 35.15 30.15 34.22 28.97 32.68
Dividend Yield
1.26% 1.25% 0.91% 0.75% 0.62% 0.46% 0.59% 1.07% 0.87% 0.96% 0.97%
Earnings Yield
3.07% 1.41% 0.15% 3.56% 2.74% 1.21% 2.84% 3.32% 2.92% 3.45% 3.06%
Enterprise Value to Invested Capital (EV/IC)
4.71 4.57 5.70 6.29 9.04 16.64 2.78 4.27 6.87 7.49 11.53
Enterprise Value to Revenue (EV/Rev)
0.99 0.99 1.42 1.70 2.44 4.16 3.21 2.06 2.99 2.94 3.57
Enterprise Value to EBITDA (EV/EBITDA)
7.89 9.47 13.55 12.27 18.75 47.03 20.52 16.53 19.35 17.31 19.82
Enterprise Value to EBIT (EV/EBIT)
11.45 15.22 21.02 16.25 26.33 85.20 25.86 24.37 25.96 21.91 24.39
Enterprise Value to NOPAT (EV/NOPAT)
17.64 16.04 204.65 21.48 29.65 48.20 32.82 31.98 34.09 28.25 30.62
Enterprise Value to Operating Cash Flow (EV/OCF)
8.74 14.88 27.23 18.82 23.33 24.91 24.75 31.58 20.09 18.51 17.23
Enterprise Value to Free Cash Flow (EV/FCFF)
11.89 17.07 0.00 35.88 34.24 37.52 0.00 3.33 26.61 24.70 21.40
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.52 0.29 0.28 0.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.29 0.29 0.28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.55 -0.60 -0.57 -0.54 -0.57 -0.63 -0.01 0.12 -0.36 -0.44 -0.52
Leverage Ratio
3.20 2.75 2.46 2.21 1.93 1.76 1.70 1.62 1.56 1.51 1.47
Compound Leverage Factor
2.27 0.83 2.44 2.14 1.89 2.33 1.92 1.96 1.69 1.66 1.61
Debt to Total Capital
34.23% 22.63% 21.80% 19.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
14.95% 0.00% 0.00% 19.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
19.28% 22.63% 21.80% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.14% -0.33% 0.01% 0.14% 0.16% 0.20% 0.13% 0.13% 0.00% 0.00% 0.00%
Common Equity to Total Capital
65.63% 77.69% 78.19% 80.29% 99.84% 99.80% 99.87% 99.87% 100.00% 100.00% 100.00%
Debt to EBITDA
2.18 1.51 1.44 1.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
-2.50 -3.10 -2.77 -2.38 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
1.23 1.51 1.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
4.86 2.56 21.68 1.84 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
-5.59 -5.25 -41.83 -4.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
2.74 2.56 21.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
2.53 2.86 3.45 3.98 5.73 7.18 6.87 5.66 7.42 8.18 9.79
Noncontrolling Interest Sharing Ratio
0.24% -0.11% -0.20% 0.10% 0.17% 0.18% 0.16% 0.13% 0.06% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.53 2.00 1.80 1.33 1.64 1.72 1.70 1.15 1.28 1.53 1.54
Quick Ratio
1.46 1.87 1.63 1.24 1.48 1.60 1.60 0.99 1.13 1.33 1.40
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
132 91 -65 82 129 198 -1,745 1,429 272 308 471
Operating Cash Flow to CapEx
664.10% 345.16% 102.31% 202.77% 417.90% 864.80% 776.91% 407.69% 1,590.80% 1,407.16% 1,719.89%
Free Cash Flow to Firm to Interest Expense
3.37 2.60 -3.29 4.97 33.87 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
4.59 2.98 4.38 9.48 49.71 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
3.90 2.12 0.10 4.81 37.82 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.63 0.68 0.78 0.81 0.85 0.81 0.85 0.91 0.92 0.93 0.97
Accounts Receivable Turnover
7.52 7.69 8.71 8.56 8.32 8.98 9.96 10.25 10.55 10.51 10.46
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
2.43 2.53 2.69 2.73 2.86 2.92 3.55 4.09 4.54 5.16 5.94
Accounts Payable Turnover
6.49 6.28 2.20 8.00 8.66 8.00 8.31 10.00 10.79 10.89 10.72
Days Sales Outstanding (DSO)
48.52 47.47 41.88 42.62 43.89 40.63 36.64 35.61 34.60 34.72 34.91
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
56.27 58.15 166.09 45.64 42.13 45.61 43.93 36.49 33.84 33.52 34.04
Cash Conversion Cycle (CCC)
-7.75 -10.69 -124.21 -3.01 1.76 -4.98 -7.29 -0.88 0.77 1.20 0.87
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
332 338 415 470 490 446 2,394 1,114 1,054 1,015 874
Invested Capital Turnover
4.46 4.64 4.43 3.94 3.78 3.81 1.46 1.32 2.24 2.50 2.99
Increase / (Decrease) in Invested Capital
-43 5.77 77 55 20 -44 1,948 -1,280 -60 -39 -142
Enterprise Value (EV)
1,565 1,546 2,362 2,956 4,431 7,421 6,660 4,759 7,244 7,601 10,073
Market Capitalization
2,059 2,056 2,844 3,527 5,113 8,301 7,733 5,244 7,953 8,512 11,241
Book Value per Share
$5.11 $5.26 $5.53 $6.31 $7.06 $7.93 $9.17 $9.66 $10.72 $11.75 $12.57
Tangible Book Value per Share
$4.43 $4.43 $4.65 $5.46 $6.22 $6.90 $8.09 $5.24 $6.46 $7.67 $8.64
Total Capital
1,260 1,091 1,148 1,296 1,174 1,328 1,541 1,600 1,763 1,927 2,041
Total Debt
431 247 250 254 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
243 247 250 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-496 -506 -483 -573 -684 -882 -1,074 -486 -709 -912 -1,168
Capital Expenditures (CapEx)
27 30 85 77 45 34 35 37 23 29 34
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-126 -153 -157 -139 -153 -246 -267 -263 -281 -243 -281
Debt-free Net Working Capital (DFNWC)
487 397 334 474 279 349 394 84 170 323 361
Net Working Capital (NWC)
299 397 334 221 279 349 394 84 170 323 361
Net Nonoperating Expense (NNE)
26 73 4.70 10 9.47 53 -17 -25 -20 -25 -15
Net Nonoperating Obligations (NNO)
-496 -506 -483 -573 -684 -882 853 -486 -709 -912 -1,168
Total Depreciation and Amortization (D&A)
62 62 62 59 68 71 67 93 95 92 95
Debt-free, Cash-free Net Working Capital to Revenue
-7.98% -9.82% -9.45% -7.94% -8.45% -13.80% -12.89% -11.39% -11.60% -9.40% -9.94%
Debt-free Net Working Capital to Revenue
30.86% 25.55% 20.06% 27.19% 15.40% 19.57% 18.97% 3.66% 7.01% 12.48% 12.79%
Net Working Capital to Revenue
18.93% 25.55% 20.06% 12.65% 15.40% 19.57% 18.97% 3.66% 7.01% 12.48% 12.79%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.38 $0.18 $0.03 $0.76 $0.84 $0.60 $1.31 $1.04 $1.41 $1.79 $2.11
Adjusted Weighted Average Basic Shares Outstanding
164.39M 161.13M 161.93M 164.85M 166.04M 166.97M 167.93M 166.87M 164.72M 164.43M 163.16M
Adjusted Diluted Earnings per Share
$0.38 $0.18 $0.03 $0.75 $0.83 $0.60 $1.31 $1.04 $1.40 $1.77 $2.09
Adjusted Weighted Average Diluted Shares Outstanding
166.42M 162.82M 164.26M 166.94M 167.55M 168.04M 168.53M 167.14M 165.66M 165.80M 164.94M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
160.21M 161.20M 164.82M 165.92M 166.40M 167.44M 167.53M 164.47M 164.10M 163.30M 161.24M
Normalized Net Operating Profit after Tax (NOPAT)
89 110 124 138 153 154 206 177 224 277 341
Normalized NOPAT Margin
5.62% 7.10% 7.42% 7.89% 8.43% 8.63% 9.92% 7.69% 9.24% 10.72% 12.08%
Pre Tax Income Margin
6.13% 1.96% 6.68% 10.10% 9.08% 6.47% 14.00% 10.22% 12.47% 14.83% 15.97%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.50 2.92 5.68 10.98 44.05 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
2.27 2.77 0.58 8.31 39.12 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
2.81 2.05 1.40 6.30 32.16 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
1.58 1.90 -3.70 3.63 27.22 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
42.33% 108.66% 380.34% 20.73% 22.58% 38.12% 20.61% 32.66% 30.00% 28.20% 32.08%
Augmented Payout Ratio
152.59% 174.48% 380.34% 20.73% 22.58% 38.12% 20.61% 93.07% 49.14% 57.14% 80.15%

Quarterly Metrics And Ratios for New York Times

This table displays calculated financial ratios and metrics derived from New York Times' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 161,238,685.00 161,862,699.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 161,238,685.00 161,862,699.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.55 0.58
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.30% 5.93% 5.80% 6.99% 7.46% 7.05% 9.72% 9.47% 10.42% 12.00% 11.17%
EBITDA Growth
33.41% 35.21% 25.18% 12.16% 9.95% 10.70% 24.20% 23.20% 5.23% 42.03% 9.96%
EBIT Growth
42.15% 65.36% 38.84% 17.78% 12.25% 14.23% 30.01% 32.34% 7.79% 61.19% 12.24%
NOPAT Growth
44.72% 78.94% 40.29% 18.84% 14.62% 29.44% 32.43% 36.89% 7.37% 78.42% 11.25%
Net Income Growth
55.74% 81.07% 40.72% 19.64% 12.23% 22.60% 26.56% 27.29% 4.94% 77.44% 12.63%
EPS Growth
59.52% 84.62% 42.86% 21.88% 10.45% 25.00% 25.00% 28.21% 6.76% 80.00% 14.00%
Operating Cash Flow Growth
107.91% 4.63% 16.19% 20.31% 11.12% 86.68% 41.64% 65.42% 8.21% -6.92% 70.95%
Free Cash Flow Firm Growth
-88.05% 221.29% 132.89% 70.46% -3.80% 64.43% 132.79% 142.76% 71.98% 35.87% 36.93%
Invested Capital Growth
-5.36% -3.69% -1.44% -3.35% -3.67% -7.46% -8.96% -14.37% -13.97% -8.98% -15.54%
Revenue Q/Q Growth
13.01% -12.16% 5.23% 2.41% 13.50% -12.48% 7.86% 2.18% 14.48% -11.23% 7.05%
EBITDA Q/Q Growth
74.82% -54.33% 44.12% -2.52% 71.37% -54.02% 61.70% -3.31% 46.38% -37.94% 25.19%
EBIT Q/Q Growth
101.89% -63.56% 65.84% -3.46% 92.40% -62.92% 88.74% -1.73% 56.71% -44.54% 31.42%
NOPAT Q/Q Growth
108.84% -65.50% 70.32% -3.17% 101.43% -61.04% 74.26% 0.09% 57.99% -35.25% 8.65%
Net Income Q/Q Growth
105.62% -63.34% 62.16% -2.13% 92.89% -59.95% 67.39% -1.56% 59.02% -32.28% 6.25%
EPS Q/Q Growth
109.38% -64.18% 66.67% -2.50% 89.74% -59.46% 66.67% 0.00% 58.00% -31.65% 5.56%
Operating Cash Flow Q/Q Growth
30.87% -61.12% 51.15% 56.43% 20.87% -34.68% 14.68% 82.69% -20.93% -43.81% 110.62%
Free Cash Flow Firm Q/Q Growth
193.65% -53.05% -0.22% 23.92% 65.72% -19.75% 41.26% 29.22% 17.40% -36.60% 42.36%
Invested Capital Q/Q Growth
-1.26% 0.73% 1.82% -4.56% -1.58% -3.23% 0.17% -10.23% -1.13% 2.38% -7.05%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
52.51% 46.66% 48.36% 48.16% 53.48% 47.38% 50.61% 50.19% 54.23% 49.04% 51.76%
EBITDA Margin
22.73% 11.82% 16.18% 15.40% 23.26% 12.22% 18.32% 17.34% 22.17% 15.49% 18.12%
Operating Margin
19.08% 8.13% 12.70% 11.99% 20.18% 9.22% 15.54% 14.95% 20.14% 12.72% 15.48%
EBIT Margin
19.18% 7.96% 12.54% 11.82% 20.04% 8.49% 14.86% 14.29% 19.56% 12.22% 15.00%
Profit (Net Income) Margin
16.30% 6.80% 10.48% 10.02% 17.03% 7.79% 12.09% 11.65% 16.18% 12.34% 12.25%
Tax Burden Percent
78.82% 72.62% 75.26% 75.42% 79.49% 77.46% 74.28% 75.60% 77.46% 89.43% 74.61%
Interest Burden Percent
107.83% 117.74% 111.09% 112.38% 106.89% 118.47% 109.57% 107.84% 106.81% 112.96% 109.47%
Effective Tax Rate
21.18% 27.38% 24.74% 24.58% 20.51% 22.54% 25.72% 24.40% 22.54% 10.57% 25.39%
Return on Invested Capital (ROIC)
33.67% 13.43% 21.89% 21.84% 40.09% 18.36% 30.05% 32.45% 46.66% 35.18% 37.89%
ROIC Less NNEP Spread (ROIC-NNEP)
32.24% 12.51% 20.96% 20.95% 39.21% 17.84% 29.59% 32.20% 46.21% 34.49% 37.39%
Return on Net Nonoperating Assets (RNNOA)
-11.46% -4.37% -7.58% -8.41% -17.22% -7.80% -13.26% -16.11% -24.22% -17.83% -20.35%
Return on Equity (ROE)
22.21% 9.06% 14.31% 13.43% 22.87% 10.56% 16.79% 16.35% 22.44% 17.34% 17.54%
Cash Return on Invested Capital (CROIC)
25.11% 24.83% 23.96% 27.64% 29.74% 35.09% 38.34% 48.94% 49.85% 48.30% 58.03%
Operating Return on Assets (OROA)
17.73% 7.68% 12.14% 11.29% 18.65% 8.33% 14.58% 13.91% 18.93% 12.67% 15.43%
Return on Assets (ROA)
15.07% 6.57% 10.15% 9.57% 15.85% 7.64% 11.87% 11.34% 15.66% 12.80% 12.60%
Return on Common Equity (ROCE)
22.19% 9.05% 14.30% 13.42% 22.87% 10.56% 16.79% 16.35% 22.44% 17.34% 17.54%
Return on Equity Simple (ROE_SIMPLE)
0.00% 14.35% 14.95% 15.14% 0.00% 16.07% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
102 35 60 58 117 45 79 79 125 81 88
NOPAT Margin
15.04% 5.91% 9.56% 9.04% 16.04% 7.14% 11.54% 11.30% 15.60% 11.38% 11.55%
Net Nonoperating Expense Percent (NNEP)
1.43% 0.92% 0.94% 0.89% 0.88% 0.52% 0.45% 0.25% 0.45% 0.69% 0.50%
Return On Investment Capital (ROIC_SIMPLE)
5.77% - - - 6.05% 2.41% 4.09% 4.00% 6.13% 4.05% 4.30%
Cost of Revenue to Revenue
47.49% 53.34% 51.64% 51.84% 46.52% 52.62% 49.39% 49.81% 45.77% 50.96% 48.24%
SG&A Expenses to Revenue
11.22% 13.27% 12.30% 11.90% 10.46% 12.57% 12.04% 10.94% 11.09% 12.14% 11.25%
R&D to Revenue
8.62% 10.64% 9.95% 9.53% 8.50% 10.46% 9.32% 9.56% 8.34% 9.86% 9.23%
Operating Expenses to Revenue
33.43% 38.52% 35.66% 36.18% 33.30% 38.16% 35.07% 35.24% 34.09% 36.32% 36.28%
Earnings before Interest and Taxes (EBIT)
130 47 78 76 146 54 102 100 157 87 114
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
154 70 101 99 169 78 126 121 178 110 138
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.51 4.04 4.65 4.92 4.42 4.28 4.70 4.70 5.51 6.73 5.51
Price to Tangible Book Value (P/TBV)
7.49 6.70 7.50 7.79 6.77 6.62 7.09 6.98 8.01 9.82 7.92
Price to Revenue (P/Rev)
3.28 2.87 3.37 3.60 3.29 3.07 3.38 3.39 3.98 4.64 3.79
Price to Earnings (P/E)
34.22 28.21 31.15 32.58 28.97 26.64 28.40 27.57 32.68 35.21 28.75
Dividend Yield
0.87% 1.02% 0.90% 0.86% 0.96% 1.05% 1.02% 1.08% 0.97% 0.86% 1.10%
Earnings Yield
2.92% 3.54% 3.21% 3.07% 3.45% 3.75% 3.52% 3.63% 3.06% 2.84% 3.48%
Enterprise Value to Invested Capital (EV/IC)
6.87 6.01 7.09 8.05 7.49 7.30 8.28 9.30 11.53 13.82 12.12
Enterprise Value to Revenue (EV/Rev)
2.99 2.59 3.08 3.27 2.94 2.73 3.03 2.99 3.57 4.26 3.38
Enterprise Value to EBITDA (EV/EBITDA)
19.35 16.25 18.57 19.59 17.31 16.06 17.30 16.88 19.82 22.85 18.21
Enterprise Value to EBIT (EV/EBIT)
25.96 21.43 24.00 25.07 21.91 20.27 21.60 20.46 24.39 27.70 21.97
Enterprise Value to NOPAT (EV/NOPAT)
34.09 27.99 31.29 32.64 28.25 25.65 27.25 25.65 30.62 33.85 26.95
Enterprise Value to Operating Cash Flow (EV/OCF)
20.09 17.58 20.50 21.00 18.51 15.70 16.63 14.37 17.23 21.39 15.31
Enterprise Value to Free Cash Flow (EV/FCFF)
26.61 23.75 29.39 28.61 24.70 19.98 20.58 17.54 21.40 27.26 19.13
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.36 -0.35 -0.36 -0.40 -0.44 -0.44 -0.45 -0.50 -0.52 -0.52 -0.54
Leverage Ratio
1.56 1.53 1.51 1.51 1.51 1.47 1.46 1.47 1.47 1.44 1.45
Compound Leverage Factor
1.68 1.80 1.68 1.70 1.61 1.75 1.60 1.59 1.57 1.63 1.59
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
7.23 7.05 8.05 8.24 7.95 8.03 8.67 8.55 9.51 11.95 9.75
Noncontrolling Interest Sharing Ratio
0.06% 0.06% 0.06% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.28 1.25 1.32 1.35 1.53 1.44 1.48 1.52 1.54 1.60 1.58
Quick Ratio
1.13 1.02 1.09 1.16 1.33 1.29 1.30 1.33 1.40 1.44 1.38
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
161 76 76 94 155 125 176 227 267 169 241
Operating Cash Flow to CapEx
2,227.05% 826.26% 1,051.52% 1,777.45% 1,882.55% 1,072.73% 1,099.44% 2,635.29% 2,512.70% 860.17% 1,921.31%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.92 0.97 0.97 0.96 0.93 0.98 0.98 0.97 0.97 1.04 1.03
Accounts Receivable Turnover
10.55 14.31 14.66 14.37 10.51 14.20 13.70 13.99 10.46 13.58 13.32
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
4.54 4.67 4.82 4.98 5.16 5.31 5.48 5.69 5.94 6.16 6.38
Accounts Payable Turnover
10.79 10.38 10.98 10.06 10.89 10.96 11.14 10.15 10.72 10.93 10.52
Days Sales Outstanding (DSO)
34.60 25.50 24.90 25.41 34.72 25.71 26.63 26.09 34.91 26.88 27.40
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
33.84 35.17 33.25 36.27 33.52 33.31 32.75 35.95 34.04 33.39 34.70
Cash Conversion Cycle (CCC)
0.77 -9.68 -8.35 -10.86 1.20 -7.61 -6.12 -9.86 0.87 -6.51 -7.30
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,054 1,062 1,081 1,032 1,015 983 984 883 874 894 831
Invested Capital Turnover
2.24 2.27 2.29 2.42 2.50 2.57 2.60 2.87 2.99 3.09 3.28
Increase / (Decrease) in Invested Capital
-60 -41 -16 -36 -39 -79 -97 -148 -142 -88 -153
Enterprise Value (EV)
7,244 6,380 7,669 8,301 7,601 7,168 8,147 8,218 10,073 12,356 10,076
Market Capitalization
7,953 7,067 8,393 9,121 8,512 8,070 9,098 9,315 11,241 13,463 11,292
Book Value per Share
$10.72 $10.62 $10.99 $11.28 $11.75 $11.54 $11.87 $12.16 $12.57 $12.41 $12.65
Tangible Book Value per Share
$6.46 $6.41 $6.81 $7.13 $7.67 $7.46 $7.87 $8.20 $8.64 $8.50 $8.80
Total Capital
1,763 1,748 1,805 1,852 1,927 1,885 1,936 1,980 2,041 2,001 2,048
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-709 -686 -724 -820 -912 -902 -952 -1,097 -1,168 -1,107 -1,216
Capital Expenditures (CapEx)
6.13 6.42 7.63 7.06 8.06 9.24 10 7.88 6.53 11 10
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-281 -243 -238 -288 -243 -275 -263 -295 -281 -245 -285
Debt-free Net Working Capital (DFNWC)
170 136 173 205 323 247 277 323 361 349 375
Net Working Capital (NWC)
170 136 173 205 323 247 277 323 361 349 375
Net Nonoperating Expense (NNE)
-8.54 -5.33 -5.77 -6.27 -7.16 -4.13 -3.80 -2.43 -4.68 -6.89 -5.37
Net Nonoperating Obligations (NNO)
-709 -686 -724 -820 -912 -902 -952 -1,097 -1,168 -1,107 -1,216
Total Depreciation and Amortization (D&A)
24 23 23 23 23 24 24 21 21 23 24
Debt-free, Cash-free Net Working Capital to Revenue
-11.60% -9.86% -9.56% -11.34% -9.40% -10.48% -9.79% -10.71% -9.94% -8.45% -9.58%
Debt-free Net Working Capital to Revenue
7.01% 5.55% 6.94% 8.10% 12.48% 9.39% 10.30% 11.74% 12.79% 12.04% 12.61%
Net Working Capital to Revenue
7.01% 5.55% 6.94% 8.10% 12.48% 9.39% 10.30% 11.74% 12.79% 12.04% 12.61%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.66 $0.25 $0.40 $0.39 $0.75 $0.30 $0.51 $0.50 $0.80 $0.54 $0.58
Adjusted Weighted Average Basic Shares Outstanding
164.72M 164.63M 164.54M 164.42M 164.43M 163.78M 163.33M 163.02M 163.16M 162.04M 162.04M
Adjusted Diluted Earnings per Share
$0.67 $0.24 $0.40 $0.39 $0.74 $0.30 $0.50 $0.50 $0.79 $0.54 $0.57
Adjusted Weighted Average Diluted Shares Outstanding
165.66M 165.63M 165.51M 165.85M 165.80M 164.91M 164.35M 164.40M 164.94M 163.70M 163.04M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
164.10M 164.31M 164.23M 163.95M 163.30M 163.05M 162.82M 162.35M 161.24M 161.86M 161.28M
Normalized Net Operating Profit after Tax (NOPAT)
102 36 61 61 119 49 82 81 128 85 92
Normalized NOPAT Margin
15.04% 6.03% 9.80% 9.58% 16.39% 7.68% 11.92% 11.56% 15.89% 11.91% 12.00%
Pre Tax Income Margin
20.68% 9.37% 13.93% 13.28% 21.42% 10.06% 16.28% 15.41% 20.89% 13.80% 16.42%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
30.00% 29.25% 28.41% 28.52% 28.20% 28.49% 29.50% 30.32% 32.08% 31.04% 32.14%
Augmented Payout Ratio
49.14% 47.70% 44.34% 50.39% 57.14% 65.30% 68.70% 70.15% 80.15% 73.60% 76.58%

Financials Breakdown Chart

Key Financial Trends

New York Times (NYSE:NYT) is showing broad improvement in revenue, profitability and financial strength through the latest reported periods. The company’s Q2 2026 results continued a multiyear growth trend, although cash flow remains influenced by investment purchases, share repurchases and working-capital fluctuations.

  • Revenue growth has been consistent. Q2 revenue increased to $762.5 million from $590.9 million in Q2 2023, a gain of approximately 29%. Q1 revenue also rose from $560.7 million in 2023 to $712.2 million in 2026, while Q3 revenue increased from $598.3 million in 2023 to $700.8 million in 2025.
  • Profitability has improved substantially. Q2 2026 gross profit was $394.6 million, up from $280.9 million in Q2 2023. The gross margin expanded to approximately 51.8% from 47.5% over that period.
  • Operating leverage is becoming more evident. Q2 operating income reached $118.0 million, compared with $55.8 million in Q2 2023. The operating margin improved to approximately 15.5% from 9.4%, despite higher marketing and research-and-development spending.
  • Net income and earnings per share have advanced. Q2 2026 net income was $93.4 million, compared with $46.6 million in Q2 2023. Diluted EPS increased to $0.57 from $0.28, although the comparison benefits partly from a lower share count.
  • Operating cash flow remains strong. Q2 2026 operating cash flow was $194.3 million, up from $69.1 million in Q2 2023. Cash generation has generally remained positive across the reported quarters, including $92.2 million in Q1 2026.
  • Liquidity has expanded. Cash and short-term investments totaled approximately $660.8 million at the end of Q2 2026, compared with $416.9 million in Q2 2023. Total current assets of $1.02 billion substantially exceeded current liabilities of $647.7 million.
  • The balance sheet carries relatively low financial risk. The supplied balance sheets do not show traditional debt, while total liabilities represented approximately 31.4% of total assets in Q2 2026. Shareholders’ equity increased to $2.05 billion from $1.61 billion in Q2 2023.
  • Capital returns to shareholders are increasing. The quarterly dividend rose to $0.23 per share in 2026 from $0.11 in 2023. The company also continued repurchasing stock, spending $35.4 million on buybacks in Q2 2026.
  • Investment activity is a major driver of cash movements. The company purchased $171.9 million of investments in Q2 2026 and sold or received maturities of $108.1 million. This produced a net investing cash outflow of $74.1 million, even though capital spending on property and equipment was only $10.1 million.
  • Recent cash flow benefited from working-capital changes. Q2 2026 operating cash flow included a $56.3 million benefit from changes in operating assets and liabilities, compared with a $4.6 million use of cash in Q2 2025. Investors should determine how much of the recent cash-flow strength is recurring.
  • Quarterly earnings remain seasonal and uneven. Q2 2026 net income of $93.4 million was below Q4 2025’s $129.8 million, and Q1 2026 net income was $87.9 million. Comparing individual quarters without considering the company’s seasonal revenue pattern could overstate or understate current momentum.
  • Financing activities continue to consume cash. Q2 2026 financing cash flow was negative $73.7 million, including $35.4 million of repurchases and $37.2 million of dividends. In Q1 2026, financing cash flow was negative $139.2 million, contributing to a $70.0 million decline in cash during the quarter.
  • Share repurchases have reduced equity but only modestly lowered the share count. Treasury stock increased to a $664.8 million deduction from equity in Q2 2026, compared with $319.9 million in Q3 2023. However, Q2 basic weighted-average shares declined only about 1.6% from Q2 2023, so buybacks have provided a limited reduction in the overall share base.
  • Operating expenses are still rising in several areas. Q2 2026 marketing expense was $85.5 million and research-and-development expense was $70.4 million, compared with $62.2 million and $56.0 million, respectively, in Q2 2023. Continued investment may support growth but could limit future margin expansion if revenue slows.

Overall, the statements point to a financially healthy company with durable top-line growth, expanding margins, strong operating cash generation and a growing liquidity cushion. The main risks are the company’s reliance on continued digital and subscription growth to support higher expenses, substantial cash deployed into investments and shareholder returns, and the possibility that recent working-capital benefits will not repeat.

09/19/26 07:49 PM ETAI Generated. May Contain Errors.

New York Times Financials - Frequently Asked Questions

According to the most recent income statement we have on file, New York Times' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

New York Times' net income appears to be on an upward trend, with a most recent value of $343.98 million in 2025, rising from $62.84 million in 2015. The previous period was $293.83 million in 2024. View New York Times' forecast to see where analysts expect New York Times to go next.

New York Times' total operating income in 2025 was $431.56 million, based on the following breakdown:
  • Total Gross Profit: $1.44 billion
  • Total Operating Expenses: $1.00 billion

Over the last 10 years, New York Times' total revenue changed from $1.58 billion in 2015 to $2.82 billion in 2025, a change of 78.9%.

New York Times' total liabilities were at $955.73 million at the end of 2025, a 4.5% increase from 2024, and a 39.9% decrease since 2015.

In the past 10 years, New York Times' cash and equivalents has ranged from $100.69 million in 2016 to $319.97 million in 2021, and is currently $255.45 million as of their latest financial filing in 2025.

Over the last 10 years, New York Times' book value per share changed from 5.11 in 2015 to 12.57 in 2025, a change of 146.2%.



Financial statements for NYSE:NYT last updated on 8/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners